Fling Pharmaceuticals Private Limited

Pharmaceutical company manufacturing and trading allopathic medicines and medical goods since 2005.

2005 | Thrissur, Kerala (India) | Active
Last Updated:

Fling Pharmaceuticals Profile

Key Indicators

  • Authorised Capital ₹ 1.00 Cr
  • Paid Up Capital ₹ 9.98 M
  • Company Age 19 Year, 4 Months
  • Last Filing with ROC 31 Mar 2023
  • Open Charges ₹ 5.10 Cr
  • Revenue Growth 29.19%
  • Profit Growth 71.65%
  • Ebitda 65.64%
  • Net Worth 46.23%
  • Total Assets 11.91%

About Fling Pharmaceuticals

Fling Pharmaceuticals Private Limited (FPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 18 November 2005 and has a history of 19 years and four months. Its registered office is in Thrissur, Kerala, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 9.98 M.

The company currently has active open charges totaling ₹5.10 Cr.

Madhu Nair, Biju Namboodiri, and David Palayoor serve as directors at the Company.

Company Details

  • Location

    Thrissur, Kerala, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U24232KL2005PTC018835

  • Company No.

    018835

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    18 Nov 2005

  • Date of AGM

    30 Sep 2023

  • Date of Balance Sheet

    31 Mar 2023

  • Listing Status

    Unlisted

  • ROC Code

    Roc Ernakulam

Industry

Pharma

Who are the key members and board of directors at Fling Pharmaceuticals?

Executive Team (1)

NameDesignationAppointment DateStatus
Madhu Nair Country flag representing In Managing Director05-May-2023Current

Board Members (2)

NameDesignationAppointment DateStatus
Biju Namboodiri Country flag representing In Whole-Time Director 11-Mar-2009Current
David Palayoor Country flag representing In Whole-Time Director 18-Nov-2005Current

Financial Performance of Fling Pharmaceuticals.

Fling Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 29.19% increase. The company also saw a substantial improvement in profitability, with a 71.65% increase in profit. The company's net worth Soared by an impressive increase of 46.23%.

Fling Pharmaceuticals revenue growth over time
Fling Pharmaceuticals profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
29.19%
Revenue from Operations
29.05%
Total Assets
11.91%
Profit or Loss
71.65%
Net Worth
46.23%
EBITDA
65.64%

What is the Ownership and Shareholding Structure of Fling Pharmaceuticals?

In 2023, Fling Pharmaceuticals had a promoter holding of 23.34% and a public holding of 76.66%. The company had 2 Subsidiaries and 2 Associate Companies. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹5.10 Cr

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions

  • Dhanlaxmi Bank Limited : 5.10 Cr

Latest Charge Details

DateLenderAmountStatus
03 Aug 2020Dhanlaxmi Bank Limited₹2.73 MOpen
06 Oct 2018Dhanlaxmi Bank Limited₹3.25 MOpen
17 Apr 2018Dhanlaxmi Bank Limited₹1.62 CrOpen
26 Mar 2018Dhanlaxmi Bank Limited₹1.50 CrOpen
22 Mar 2017Dhanlaxmi Bank Limited₹7.00 MOpen

How Many Employees Work at Fling Pharmaceuticals?

Fling Pharmaceuticals has a workforce of 40 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee growth trends for Fling Pharmaceuticals Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Fling Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Fling Pharmaceuticals's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Fling Pharmaceuticals

Recent activity within the organization

  • Annual General Meeting

    Fling Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.

  • Charges

    A charge with Dhanlaxmi Bank Limited of Rs. 1.62 Cr registered on 17 Apr 2018 with Charge ID 100176290 was modified on 12 Jul 2023.

  • Director Appointment

    Madhu Karuvanchery Vijayan Nair was appointed as a Managing Director was appointed as a Managing Director on 05 May 2023 & has been associated with this company since 1 year 10 months .

  • Balance Sheet

    Fling Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Ernakulam.

  • Charges

    A charge with Dhanlaxmi Bank Limited amounted to Rs. 0.27 Cr with Charge ID 100361213 was registered on 03 Aug 2020.

  • Charges

    A charge with Dhanlaxmi Bank Limited amounted to Rs. 0.33 Cr with Charge ID 100210398 was registered on 06 Oct 2018.

Frequently asked questions

  • What is the Incorporation or founding date of Fling Pharmaceuticals Private Limited?

    Fling Pharmaceuticals Private Limited was incorporated on 18 Nov 2005.

  • What is authorized share capital and paid-up capital of Fling Pharmaceuticals Private Limited?

    The authorized share capital of Fling Pharmaceuticals Private Limited is ₹ 1.00 Cr and paid-up capital is ₹ 9.98 M.

  • Who are the current board members & directors of Fling Pharmaceuticals Private Limited?

    Currently 3 directors are associated with Fling Pharmaceuticals Private Limited.

    • Madhu Karuvanchery Vijayan Nair
    • Biju Kapplingattu Krishnan Namboodiri
    • David Joseph Palayoor

  • What is the registered address of Fling Pharmaceuticals Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Fling Pharmaceuticals Private Limited is No. B1 31/441/5 First Floor Navamy Regency Sitaram Mill Road, Punkunnam P.O. India, Thrissur, Kerala, 680002.

  • What is the corporate identification number (CIN) and company number of Fling Pharmaceuticals Private Limited?

    The corporate identification number (CIN) of Fling Pharmaceuticals Private Limited is U24232KL2005PTC018835 and the company number is 018835 as per Ministry of Corporate Affairs (MCA).

  • What has been the recent revenue trend for Fling Pharmaceuticals Private Limited?

    According to the financial reports for the fiscal year 2023, the revenue trend for Fling Pharmaceuticals Private Limited has risen by 29.19%.

  • How many employees does Fling Pharmaceuticals Private Limited currently have?

    As Per 2023 financial reports, 40 employees are currently employed by Fling Pharmaceuticals Private Limited.

  • What change has been observed in the net worth of Fling Pharmaceuticals Private Limited, and by what percentage?

    The financial reports for the fiscal year 2023 indicates that The net worth of Fling Pharmaceuticals Private Limited has experienced an upsurge of 46.23%.

  • What are the total open charges for Fling Pharmaceuticals Private Limited?

    As per the financial statements for fiscal Year 2023, The total open charges for Fling Pharmaceuticals Private Limited amount to ₹ 5.10 Cr.

  • When was the last Balance Sheet of Fling Pharmaceuticals Private Limited filed with the ROC?

    The most recent Balance Sheet for Fling Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2023.

People also Viewed